Kissei Pharmaceutical Co., Ltd.
Notice of Share Buyback Status | June 2026
Kissei Pharmaceutical Co., Ltd. planned to acquire treasury shares based on the board of directors' resolution on May 11, 2026, from May 12, 2026, to December 31, 2026. However, the actual number of shares acquired was 0 shares, and the total amount was 0 yen.
Key Figures
- Total Number of Shares Acquired: 0 shares
- Total Acquisition Cost: 0 yen
- Acquisition Period: May 12, 2026 – December 31, 2026
AI要約
Overview of Capital Policy
Kissei Pharmaceutical Co., Ltd. planned to acquire up to 1,300,000 shares (3.14% of total issued shares) as treasury stock following the board resolution on May 11, 2026. As of May 31, 2026, the cumulative total acquired shares remain at 0, and the total acquisition amount is also 0 yen. The acquisition method involved a market purchase on the Tokyo Stock Exchange and was based on an entrusted trading agreement.
Future Outlook and Impact on Shareholders
The results show that the intended acquisition was not realized, indicating that the share buyback as part of the capital policy has possibly been postponed. Further announcements will be needed regarding future capital policies and shareholder return strategies. Investors should closely monitor the implementation status of the share buyback and future policy directions.
Kissei Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
